Key terms

About ALDX

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ALDX news

Apr 08 3:18pm ET Fly Insider: Xilio, Aerovate among week’s notable insider trades by TipRanks Apr 05 10:40am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 03 7:27am ET Oppenheimer more bullish on Aldeyra, upgrades to Outperform by TipRanks Apr 03 7:08am ET Aldeyra upgraded to Outperform from Perform at Oppenheimer by TipRanks Apr 02 6:20am ET Analysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX), Carisma Therapeutics (CARM) and Panbela Therapeutics (OtherPBLA) by TipRanks Mar 28 7:15am ET Aldeyra in FDA clinical plan for NDA resubmission of reproxalap for DED by TipRanks Mar 28 7:12am ET Aldeyra Therapeutics Unveils Reproxalap Development Update by TipRanks Mar 13 2:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Mar 10 5:27pm ET Strong Buy Rating for Aldeyra Therapeutics Backed by Reproxalap Developments and Strategic Partnerships by TipRanks Mar 07 4:56pm ET Aldeyra files $200M mixed securities shelf by TipRanks Mar 04 10:50am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 13 4:13pm ET Aldeyra CEO Speaks at Oppenheimer Healthcare Conference by TipRanks

No recent news articles are available for ALDX

Yesterday 4:45am ET Attention Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors: Grabar Law Office Is Investigating Claims on Your Behalf by Newsfile Mar 29 10:40am ET Attention Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors by Newsfile Mar 27 5:21pm ET Notice to Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors by Newsfile Mar 20 9:40am ET Grabar Law Office Investigates Claims on Behalf of Shareholders of Aldeyra Therapeutics, Inc. (ALDX) by Newsfile

ALDX Financials

1-year income & revenue

Key terms

ALDX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ALDX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel